Irbesartan in patients with atrial fibrillation.

There was no benefit of irbesartan in preventing hospitalization for atrial fibrillation or atrialfibrillation recorded on 12-lead electrocardiography, nor was there a benefit in a subgroup that underwent transtelephonic monitoring.